In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
DSM and Caliber Therapeutics to develop novel drug delivery device
DSM obtains exclusive world-wide license for innovative drug delivery technology
pSivida signs evaluation agreement for cardiovascular drug delivery
Boston Life Sciences takes steps to further Its focus on neurology
Boston Life Sciences signs licensing agreement with Pfizer
PRO-PHARMACEUTICALS RETAINS HANIFY & KING'S LIFE SCIENCES GROUP TO PURSUE COLLABORATIONS
pSivida signs new evaluation agreement for cardiovascular drug delivery
Boston Life Sciences announces identification of Troponin I analogue